Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a simple drug cut blood loss in baby skull surgery?

NCT ID NCT02229968

First seen Apr 29, 2026 · Last updated May 20, 2026 · Updated 6 times

Summary

This study tests whether a medicine called Amicar can reduce blood loss in children aged 2 to 36 months who need skull surgery for a condition called craniosynostosis. The goal is to see if it lowers the need for blood transfusions during and after the operation. The study involves 22 children and is in Phase 2.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CRANIOSYNOSTOSIS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

Conditions

Explore the condition pages connected to this study.